Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|June 13, 2025
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and CyclosporinDavid J Curtis, Sushrut S Patil, John Reynolds, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Internal Medicine Journal|May 3, 2025
Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern eraLuani Barge, Steven Tran, Glen Kennedy, et al.
Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2012
Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancyVanderson Rocha, Stephen Spellman, Mei-Jie Zhang, et al.
Hematological Oncology|April 16, 2019
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphomaZi Yun Ng, Mark Bishton, David Ritchie, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Transplantation and Cellular Therapy|February 27, 2024
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
Bone Marrow Transplantation|February 27, 2024
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 updateSeth J Rotz, Neel S Bhatt, Betty K Hamilton, et al.
Pageof 6